Multigam IV

intravenous immunoglobulin (IGIV)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Multigam IV, covering 2019-11-15 to 2019-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder